Research Info

Home /The non-templating synthesis ...
Title The non-templating synthesis of macro-cyclic Schiff base ligands containing pyrrole and homopiperazine and their binuclear nickel(II), cobalt(II) and mononuclear platinum(II) complexes: X-ray single crystal and anticancer studies
Type JournalPaper
Keywords Mannich reaction Macro-cyclic Schiffbase ligands Bi-nuclear macro-cyclic complexes Cytotoxicity
Abstract A new dialdehyde N, N’-bis(5-formylpyrrol-2-ylmethyl) homopiperazine (A) was synthesized by the Man- nich reaction of pyrrole 2-carbaldehyde, formaldehyde and homopiperazine in the presence of hydrochlo- ric acid. From the direct reaction of A with 1,3-diaminopropane or 1,4- diaminobutane two new macro- cyclic Schiffbase ligands were obtained, L 1 and L 2 , respectively. The reaction of these ligands with Ni(II), Co(II) and Pt(II) metal ions results in formation of the relevant macrocyclic Schiffbase complexes. Com- pounds were characterized by FT-IR, elemental analysis, mass spectrometry, UV-Vis and, in the case of the ligands, by 1 H and 13 C-NMR. The crystal structure of the complex [Ni 2 L 2 (CH 3 O)]ClO 4 (4) showed a binuclear macro-cyclic structure, with each Ni coordinated by three nitrogen atoms from the ligand and by a methoxide bridging the two metal centers. The cytotoxic activities of these compounds indicated that the ligands, and some of the complexes, have high anti-proliferative effect towards A549 and HeLa cells, but not HT29 cells. Pt complex with L 1 and L 2 displayed stronger anti-proliferative activity toward HeLa (IC50 = 11 μM for both of them and A549 IC50 = 7 μM and 8 μM, respectively) relative to L 1 and L 2 . In addition, the cytotoxic effects of the compounds were assayed in rat fibroblast cells as a model of the normal cell, however none of them showed any significant cytotoxic effects. Thereby upholding the potential of these compounds for further development as chemotherapeutic agents.
Researchers ROBERT W. GABLE (Fourth Researcher), Leila Hosseinzadeh (Third Researcher), Hassan Keypour (Second Researcher), (First Researcher)